Apollon, a developer of needle-free continuous glucose monitoring (CGM) systems, announced on September 23 that it has raised KRW 5 billion (approximately $3.7 million) in a Series A funding round. This brings the startup's cumulative capital to over KRW 10 billion, combining private equity investment and government R&D grants. The financing round was led by SBI Investment, with strategic participation from Naver—ahead of the launch of its dedicated digital healthcare divisio